Back
Varex Imaging 10K Form
Sell
49
VREX
Varex Imaging
Last Price:
13.25
Seasonality Move:
12.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2023-08-01 | 10Q | VREX/Varex Imaging Quarterly |
2023-05-02 | 10Q | VREX/Varex Imaging Quarterly |
2023-01-31 | 10Q | VREX/Varex Imaging Quarterly |
2022-08-03 | 10Q | VREX/Varex Imaging Quarterly |
2022-05-04 | 10Q | VREX/Varex Imaging Quarterly |
2022-02-08 | 10Q | VREX/Varex Imaging Quarterly |
Receive VREX News And Ratings
See the #1 stock for the next 7 days that we like better than VREX
VREX Financial Statistics
Sales & Book Value
Annual Sales: | $893.4M |
---|---|
Cash Flow: | $3.3M |
Price / Cash Flow: | 12.84 |
Annual Sales: | $14.22 |
Price / Book: | 0.93 |
Profitability
EPS (TTM): | 0.71000 |
---|---|
Net Income (TTM): | $34.2M |
Gross Margin: | $290.3M |
Return on Equity: | 5.91% |
Return on Assets: | 2.76% |
Varex Imaging Earnings Forecast
Key Varex Imaging Financial Ratios
- The Gross Profit Margin over the past 11 years for VREX is 32.49%.
- The Selling, General & Administrative Expenses for VREX have been equal to 14.37% of Gross Profit Margin.
- The Research & Development expenses have been 9.49% of Revenue.
- The Interest Expense is 55.39% of Operating Income.
- The Net Earning history of VREX is 5.40% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 4 years.
Varex Imaging Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | VREX |
CUSIP: | 92214X |
Website: | vareximaging.com |
Debt
Debt-to-Equity Ratio: | 0.76 |
---|---|
Current Ratio: | 3.34 |
Quick Ratio: | 1.76 |
Price-to-Earnings
Trailing P/E Ratio: | 12.27 |
---|---|
Forward P/E Ratio: | 13.08 |
VREX Technical Analysis vs Fundamental Analysis
Sell
49
Varex Imaging (VREX)
is a Sell
Is Varex Imaging a Buy or a Sell?
-
Varex Imaging stock is rated a Sell
The current Varex Imaging [VREX] share price is $13.25. The Score for VREX is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.